154 related articles for article (PubMed ID: 2190554)
1. Substitution of proline with pipecolic acid at the scissile bond converts a peptide substrate of HIV proteinase into a selective inhibitor.
Copeland TD; Wondrak EM; Tozser J; Roberts MM; Oroszlan S
Biochem Biophys Res Commun; 1990 May; 169(1):310-4. PubMed ID: 2190554
[TBL] [Abstract][Full Text] [Related]
2. Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases.
Phylip LH; Richards AD; Kay J; Kovalinka J; Strop P; Blaha I; Velek J; Kostka V; Ritchie AJ; Broadhurst AV
Biochem Biophys Res Commun; 1990 Aug; 171(1):439-44. PubMed ID: 2203349
[TBL] [Abstract][Full Text] [Related]
3. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.
Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow C; Reardon IM; Howe WJ; DeCamp DL; Craik CS; Heinrikson RL
J Biol Chem; 1990 Aug; 265(24):14675-83. PubMed ID: 2201691
[TBL] [Abstract][Full Text] [Related]
4. Rational design of peptide-based HIV proteinase inhibitors.
Roberts NA; Martin JA; Kinchington D; Broadhurst AV; Craig JC; Duncan IB; Galpin SA; Handa BK; Kay J; Kröhn A
Science; 1990 Apr; 248(4953):358-61. PubMed ID: 2183354
[TBL] [Abstract][Full Text] [Related]
5. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer.
Matayoshi ED; Wang GT; Krafft GA; Erickson J
Science; 1990 Feb; 247(4945):954-8. PubMed ID: 2106161
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibition of HIV-1 proteinase by cerulenin.
Moelling K; Schulze T; Knoop MT; Kay J; Jupp R; Nicolaou G; Pearl LH
FEBS Lett; 1990 Feb; 261(2):373-7. PubMed ID: 1690152
[TBL] [Abstract][Full Text] [Related]
7. Modified oligopeptides designed to interact with the HIV-1 proteinase inhibit viral replication.
Grinde B; Hungnes O; Tjøtta E
Arch Virol; 1990; 114(3-4):167-73. PubMed ID: 2241573
[TBL] [Abstract][Full Text] [Related]
8. Sensitive, soluble chromogenic substrates for HIV-1 proteinase.
Richards AD; Phylip LH; Farmerie WG; Scarborough PE; Alvarez A; Dunn BM; Hirel PH; Konvalinka J; Strop P; Pavlickova L
J Biol Chem; 1990 May; 265(14):7733-6. PubMed ID: 2186027
[TBL] [Abstract][Full Text] [Related]
9. Studies on the role of the S4 substrate binding site of HIV proteinases.
Tözsér J; Gustchina A; Weber IT; Blaha I; Wondrak EM; Oroszlan S
FEBS Lett; 1991 Feb; 279(2):356-60. PubMed ID: 2001747
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of homologous peptides using fragment condensation: analogs of an HIV proteinase substrate.
Bláha I; Nemec J; Tözsér J; Oroszlan S
Int J Pept Protein Res; 1991 Nov; 38(5):453-8. PubMed ID: 1802863
[TBL] [Abstract][Full Text] [Related]
11. Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus.
Grobelny D; Wondrak EM; Galardy RE; Oroszlan S
Biochem Biophys Res Commun; 1990 Jun; 169(3):1111-6. PubMed ID: 2114105
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase.
Partin K; Kräusslich HG; Ehrlich L; Wimmer E; Carter C
J Virol; 1990 Aug; 64(8):3938-47. PubMed ID: 2196384
[TBL] [Abstract][Full Text] [Related]
13. Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.
Tomasselli AG; Olsen MK; Hui JO; Staples DJ; Sawyer TK; Heinrikson RL; Tomich CS
Biochemistry; 1990 Jan; 29(1):264-9. PubMed ID: 2182116
[TBL] [Abstract][Full Text] [Related]
14. Sub-site preferences of the aspartic proteinase from the human immunodeficiency virus, HIV-1.
Konvalinka J; Strop P; Velek J; Cerna V; Kostka V; Phylip LH; Richards AD; Dunn BM; Kay J
FEBS Lett; 1990 Jul; 268(1):35-8. PubMed ID: 2200711
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyethylamine analogues of the p17/p24 substrate cleavage site are tight-binding inhibitors of HIV protease.
Rich DH; Green J; Toth MV; Marshall GR; Kent SB
J Med Chem; 1990 May; 33(5):1285-8. PubMed ID: 2184237
[No Abstract] [Full Text] [Related]
16. Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease.
Margolin N; Heath W; Osborne E; Lai M; Vlahos C
Biochem Biophys Res Commun; 1990 Mar; 167(2):554-60. PubMed ID: 2182016
[TBL] [Abstract][Full Text] [Related]
17. Subsite preferences of retroviral proteinases.
Dunn BM; Gustchina A; Wlodawer A; Kay J
Methods Enzymol; 1994; 241():254-78. PubMed ID: 7854181
[No Abstract] [Full Text] [Related]
18. Affinity purification of the HIV-1 protease.
Heimbach JC; Garsky VM; Michelson SR; Dixon RA; Sigal IS; Darke PL
Biochem Biophys Res Commun; 1989 Nov; 164(3):955-60. PubMed ID: 2686642
[TBL] [Abstract][Full Text] [Related]
19. Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor.
Jaskólski M; Tomasselli AG; Sawyer TK; Staples DG; Heinrikson RL; Schneider J; Kent SB; Wlodawer A
Biochemistry; 1991 Feb; 30(6):1600-9. PubMed ID: 1993177
[TBL] [Abstract][Full Text] [Related]
20. Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease.
Erickson J; Neidhart DJ; VanDrie J; Kempf DJ; Wang XC; Norbeck DW; Plattner JJ; Rittenhouse JW; Turon M; Wideburg N
Science; 1990 Aug; 249(4968):527-33. PubMed ID: 2200122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
